Evidence map›Paper›PMID 40475879›Full record

ArticleCochrane evidence synthesis and methods2024

Developing CAMELOT for assessing methodological limitations of qualitative research for inclusion in qualitative evidence syntheses.

Heather M Munthe-Kaas, Andrew Booth, Isolde Sommer, Sara Cooper, Ruth Garside, Karin Hannes, Jane Noyes, CAMELOT Development Group

Abstract read
In one paragraph

Article in Cochrane evidence synthesis and methods, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 5 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 5 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Review
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Heather M Munthe-KaasCentre for Epidemic Interventions Research Norwegian Institute of Public Health Oslo Norway.ORCID https://orcid.org/0000-0002-6051-9010
Andrew BoothSheffield Centre for Health & Related Research (SCHARR) University of Sheffield Sheffield UK.ORCID https://orcid.org/0000-0003-4808-3880
Isolde SommerDepartment for Evidence-based Medicine and Evaluation University for Continuing Education Krems Krems Austria.ORCID https://orcid.org/0000-0003-3592-1507
Sara CooperCochrane South Africa South African Medical Research Council Cape Town South Africa.ORCID https://orcid.org/0000-0002-9627-0309
Ruth GarsideUniversity of Exeter Exeter UK.ORCID https://orcid.org/0000-0003-1649-4773
Karin HannesResearch Group SoMeTHin'K, Faculty of Social Sciences KU Leuven Leuven Belgium.ORCID https://orcid.org/0000-0002-5011-3615
Jane NoyesSchool of Medical and Health Sciences Bangor University Bangor UK.ORCID https://orcid.org/0000-0003-4238-5984
CAMELOT Development Group

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Qualitative evidence is increasingly incorporated into decision-making processes. Assessing the methodological limitations of primary studies is critical to making an overall assessment of confidence in findings from qualitative evidence syntheses (QES) using GRADE-CERQual. Current critical appraisal tools were not developed specifically for use in Cochrane reviews or GRADE-CERQual, and few are evidence-based. The aim of CochrAne qualitative Methodological LimitatiOns Tool (CAMELOT) was to address this gap. Methods: We undertook this project in four stages: (1) systematic literature search to identify existing tools, (2) identification of evidence to support inclusion of potential CAMELOT domains (3) consensus survey to agree on the inclusion and definition of CAMELOT domains, and (4) human-centered design approach to develop and refine CAMELOT by exploring user experience. Results: CAMELOT is a new evidence-based tool for assessing the methodological strengths and limitations of primary qualitative research studies in a QES. CAMELOT is comprised of 12 domains: four Conclusion: CAMELOT provides review authors with a transparent and systematic method to assess methodological limitations of primary qualitative studies. CAMELOT incorporates qualitative principles and focuses on appropriateness of fit between

Indexed as

consensus developmentcritical appraisalDelphiGRADE‐CERQualmethodological limitationsqualitative evidence synthesisqualitative research

Identifiers

PMID40475879
PMCPMC11795985

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.